This week, ZenPharm, the Maltese joint venture with Canadian cannabis producer, Zenabis Global, received its Maltese licence to process cannabis for medicinal use and research purposes out of its Hal Far Industrial Estate premises.
Kurt Farrugia, CEO of Malta Enterprise – the national economic development agency that assisted the company to set up locally – considers this “an important milestone for Malta’s medical cannabis industry.”
“We are gaining momentum with the production of cannabis for medical use in Malta,” he wrote. “Zenabis – a Maltese joint venture and partner of Zenpharm, have received a licence for the production of medical cannabis in their facility in Hal Far, Malta.”
The CEO said that the issuing of the second licence for the production of cannabis for medical use shows that “Malta is becoming a centre of excellence in such an important emerging sector.”
“Those companies strive hard to achieve the Medicine’s Authority pharmaceutical standards. Now that they do, patients can rest assured that the Made in Malta product is top quality. A gold standard for the industry. This is indeed a proud moment.”
Through its licence, ZenPharm plans to ship around 500kg of cannabis out of Malta annually to EU countries, with the largest market being Germany.
Featured Image:
Kurt Farrugia / LinkedIn
‘As a stock exchange, we recognise the challenges companies face’ – MSE Exec Chairman Joseph Portelli
Malta Stock Exchange will hold its first annual Governance, Risk and Compliance Summit on 2nd February 2023.
Emanuel Zammit pinpoints five reasons why counteroffers ‘do not work’ and should be avoided
The recruitment specialist explains how underlying issues cannot simply be solved through counteroffers.
Albert Bonello appointed Managing Director Finance and Administration at AX Group
Nicky Camilleri has also been named Chief Operations Officer at the group.
Maris Catania commences consultancy journey with launch of Integrity Analytics
Her time at iGaming firm Kindred Group came to an end last December as she opted to focus on a ...
